Brief: Opko Health And Entera Bio Expand Partnership To Advance First-In-Class Oral Long Acting Pth Tablet For Patients With Hypoparathyroidism
04/02/2026 13:07
Feb 4 (Reuters) - Entera Bio Ltd 5DT.F: OPKO HEALTH AND ENTERA BIO EXPAND PARTNERSHIP TO ADVANCE FIRST-IN-CLASS ORAL LONG ACTING PTH TABLET FOR PATIENTS WITH HYPOPARATHYROIDISM Source text: ID:nGNX30wmGy Further company coverage: 5DT.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on OPKO Health
See all newsOpko Health, Inc. Expected To Post A Loss Of 7 Cents A Share: Earnings Preview
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
US RESEARCH ROUNDUP-Bank7, Goldman Sachs, Morgan Stanley
Deals of the day-Mergers and acquisitions
US STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons